[1]何俊见,刘洪祥,霍佳宁,等.高迁移率族蛋白-1和晚期糖基化终末产物受体 在多囊卵巢综合征大鼠模型中的表达[J].中国计划生育和妇产科,2019,(6):20-23.
　HE Jun-jian,LIU Hong-xiang,HUO Jia-ning,et al.Expression of HMGB 1 and RAGE in rat model of polycystic ovary syndrome[J].Chinese Journal of Family Planning & Gynecotokology,2019,(6):20-23.
点击复制

高迁移率族蛋白-1和晚期糖基化终末产物受体 在多囊卵巢综合征大鼠模型中的表达
分享到：

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2019年6期
页码:
20-23
栏目:
论著与临床
出版日期:
2019-06-25

文章信息/Info

Title:
Expression of HMGB 1 and RAGE in rat model of polycystic ovary syndrome
作者:
何俊见; 刘洪祥; 霍佳宁; 李怡冰; 马晓欣*
中国医科大学附属盛京医院妇产科
Author(s):
HE Jun-jian; LIU Hong-xiang;  HUO Jia-ning;  LI Yi-bing;  MA Xiao-xin*
Department of Obstetrics and Gynecology,Shengjing Hospital of China Medical University,Shenyang Liaoning 110004,P.R.China
关键词:
多囊卵巢综合征; 高迁移率族蛋白-1; 晚期糖基化终末产物受体; 大鼠; 动物模型
Keywords:
polycystic ovary syndrome; HMGB 1;  RAGE; rat; animal model
分类号:
R 737.31
摘要:
目的研究高迁移率族蛋白-1（high-mobility group box-1，HMGB 1）和晚期糖基化终末产物受体（receptor for advanced glycation end products，RAGE）在多囊卵巢综合征（polycystic ovary syndrome，PCOS）大鼠模型卵巢组织中的表达。 方法采用脱氢表雄酮联合高脂饮食造模法建立PCOS大鼠模型，造模成功后用Real-time PCR和Western-Blot检测HMGB 1和RAGE的表达，用免疫组织化学染色检测HMGB 1的表达。 结果HMGB 1 mRNA、RAGE mRNA、HMGB 1蛋白、RAGE蛋白在研究组的表达量均高于对照组，差异均有统计学意义（P＜005）。结论研究组大鼠卵巢组织中的HMGB1和RAGE的表达量均明显高于对照组，提示HMGB 1和RAGE 可能在PCOS的发生发展中有一定作用。
Abstract:
ObjectiveTo investigate the expression of high-mobility group box-1(HMGB 1) and receptor for advanced glycation end products(RAGE) in the ovarian tissue of the polycystic ovary syndrome(PCOS) rat model. MethodsThe PCOS rat model was established by dehydroepiandrosterone combined with high-fat diet. After successful modeling, the expression of HMGB 1 and RAGE was detected by Real-time PCR and Western-Blot, and the expression of HMGB 1 was detected by immunohistochemical staining. ResultsThe expression of HMGB 1 mRNA RAGE mRNA, HMGB 1 protein,RAGE Protein in the study group were higher than those in the control group, the differences were statistically significant (P＜005).ConclusionThe expression levels of HMGB 1 and RAGE in the ovarian tissue of the study group were significantly higher than those in the ovary of the control group. This suggests that HMGB 1 and RAGE may play a role in the development of PCOS.

参考文献/References:

［1］BOZDAG G, MUMUSOGLU S, ZENGIN D, et al. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis ［J］. Human Reproduction, 2016, 31 (12): 2841-2855. ［2］LI Rong, ZHANG Qiufang, YANG Dongzi, et al. Prevalence of polycystic ovary syndrome in women in China: a large community-based study ［J］. Human Reproduction (Oxford, England), 2013, 28 (9): 2562-2569. ［3］ESCOBAR-MORREALE H F. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment ［J］. Nature Reviews Endocrinology, 2018, 14 (5): 270-284. ［4］RILEY J K, JUNGHEIM E S. Is there a role for diet in ameliorating the reproductive sequelae associated with chronic low-grade inflammation in polycystic ovary syndrome and obesity? ［J］. Fertility and Sterility, 2016, 106 (3): 520-527. ［5］MACUT D, BJEKIC-MACUT J, RAHELIC D, et al. Insulin and the polycystic ovary syndrome ［J］. Diabetes Research and Clinical Practice, 2017, 130(8):163-170. ［6］JOHAM A E, TEEDE H J, RANASINHA S, et al. Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community-based cohort study ［J］. Journal of Women's Health, 2015, 24 (4): 299-307. ［7］MISSO M L, TEEDE H J, HART R, et al. Status of clomiphene citrate and metformin for infertility in PCOS ［J］. Trends in Endocrinology and Metabolism, 2012, 23 (10): 533-543. ［8］WU Han, CHEN Zheng, XIE Jun, et al. High mobility group Box-1: A missing Link between diabetes and its complications ［J］. Mediators of Inflammation, 2016 (10): 1-11. ［9］FRITZ G. RAGE: a single receptor fits multiple ligands ［J］. Trends in Biochemical Sciences, 2011, 36 (12): 625-632. ［10］刘洪祥．脱氢表雄酮联合高脂饮食诱导大鼠PCOS模型的研究 ［D］．沈阳：中国医科大学，2018． ［11］SPRITZER P M, LECKE S B, SATLER F, et al. Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome ［J］. Reproduction, 2015, 149 (5): R 219-R 227. ［12］LIM S S, DAVIES M J, NORMAN R J, et al. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis［J］. Human Reproduction Update, 2012, 18(6): 618-637. ［13］DIAMANTI-KANDARAKIS E, DUNAIF A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications ［J］. Endocrine Reviews, 2012, 33 (6): 981-1030. ［14］AYTAN A N, BASTU E, DEMIRAL I, et al. Relationship between hyperandrogenism, obesity, inflammation and polycystic ovary syndrome ［J］. Gynecological Endocrinology, 2016, 32 (9): 709-713. ［15］SCHMIDT J, WEIJDEGARD B, MIKKELSEN A L, et al. Differential expression of inflammation-related genes in the ovarian stroma and granulosa cells of PCOS women ［J］. Molecular Human Reproduction, 2014, 20 (1): 49-58. ［16］ZHAO Yu-e, ZHANG Chun-mei, HUANG Ying, et al. Up-regulated expression of WNT5a increases inflammation and oxidative stress via PI3K/AKT/NF-kappa B signaling in the granulosa cells of PCOS patients ［J］. Journal of Clinical Endocrinology & Metabolism, 2015, 100 (1): 201-211. ［17］LI Da, YOU Yu-e, BI Fang-fang, et al. Autophagy is activated in the ovarian tissue of polycystic ovary syndrome ［J］. Reproduction, 2018, 155 (1): 85-92. ［18］ Pea-Oyarzun D,Bravo-Sagua R,Diaz-Vega A, et al. Autophagy and oxidative stress in non-communicable diseases: A matter of the inflammatory state? ［J］. Free Radical Biology and Medicine, 2018, 124 (8): 61-78. ［19］MUSUMECI D, ROVIELLO G N, MONTESARCHIO D. An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies ［J］. Pharmacology & Therapeutics, 2014, 141(3): 347-357. ［20］ANDERSSON U, YANG H, HARRIS H. High-mobility group box 1 protein (HMGB1) operates as an alarmin outside as well as inside cells ［J］. Seminars in Immunology, 2018,38(8):40-48. ［21］DIENER K R, AL-DASOOQI N, LOUSBERG E L, et al. The multifunctional alarmin HMGB1 with roles in the pathophysiology of sepsis and cancer ［J］. Immunology and Cell Biology, 2013, 91 (7): 443-450. ［22］YANG Huan, ANTOINE D J, ANDERSSON U, et al. The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis ［J］. Journal of Leukocyte Biology, 2013, 93 (6): 865-873. ［23］SOMAN S, RAJU R, SANDHYA V K, et al. A multicellular signal transduction network of AGE/RAGE signaling ［J］. Journal of Cell Communication and Signaling, 2013, 7 (1): 19-23. ［24］WANG Xin-ling, YU Tao, YAN Qi-chang, et al. AGEs promote oxidative stress and induce apoptosis in retinal pigmented epithelium cells RAGE-dependently ［J］. Journal of Molecular Neuroscience : MN, 2015, 56 (2): 449-460. ［25］XIE Ying, YOU Shou-jiang, ZHANG Yan-lin, et al. Protective role of autophagy in AGE-induced early injury of human vascular endothelial cells ［J］. Molecular Medicine Reports, 2011, 4 (3): 459-464. ［26］ZHANG Jing-liang, SHAO Shuai, HAN Dong-hui, et al. High mobility group box 1 promotes the epithelial-to-mesenchymal transition in prostate cancer PC3 cells via the RAGE/NF-B signaling pathway ［J］. International Journal of Oncology, 2018, 53 (2): 659-671. ［27］HUDSON B I, LIPPMAN M E. Targeting RAGE Signaling in Inflammatory Disease ［J］. Annual Review of Medicine, 2018,69(1):349-364. ［28］LEE B W, CHAE H Y, KWON S J, et al. RAGE ligands induce apoptotic cell death of pancreatic beta-cells via oxidative stress ［J］. International Journal of Molecular Medicine, 2010, 26 (6): 813-818. ［29］SONG Fei, DEL POZO C H, ROSARIO R, et al. RAGE regulates the metabolic and inflammatory response to High-Fat feeding in mice ［J］. Diabetes, 2014, 63 (6): 1948-1965. ［30］赵彦楠，刘洪祥，霍佳宁，等．晚期糖基化终末产物在多囊卵巢综合征大鼠模型中的表达 ［J］．中国医科大学学报，2017，46（5）：388-391． ［31］KANDARAKI E A, CHATZIGEORGIOU A, PAPAGEORGIOU E, et al. Advanced glycation end products interfere in luteinizing hormone and follicle stimulating hormone signaling in human granulosa KGN cells ［J］. Experimental Biology and Medicine, 2018, 243 (1): 29-33.

相似文献/References:

[1]姜荣华,钟小英,潘萍,等.61例多囊卵巢综合征妇女行供精人工授精结局分析[J].中国计划生育和妇产科,2011,(04):0.
　JIANG Rong-hua,ZHONG Xiao-ying,PAN Ping.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(6):0.
[2]任涛,熊小英,蔡春芳,等.多囊卵巢综合征患者视黄醇结合蛋白-4的水平变化及意义[J].中国计划生育和妇产科,2013,(04):0.
　REN Tao *,XIONG Xiao-ying,CAI Chun-fang.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(6):0.
[3]龚衍,曾玖芝,李运星,等.不同剂量来曲唑对多囊卵巢综合征不孕症患者诱导排卵的临床观察[J].中国计划生育和妇产科,2013,(05):0.
　GONG Yan,ZENG Jiu-zhi,Li Yun-xing,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(6):0.
[4]李琳.无生育要求多囊卵巢综合征患者无排卵的处理[J].中国计划生育和妇产科,2014,(04):0.
　LI Lin,[J].Chinese Journal of Family Planning & Gynecotokology,2014,(6):0.
[5]刘振腾,郝翠芳.有生育要求的多囊卵巢综合征患者的治疗[J].中国计划生育和妇产科,2014,(04):0.
　LIU Zhen-teng,HAO Cui-fang,Reproductive Medical Center,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(6):0.
[6]李淑红.腹腔镜下卵巢表面电凝术治疗多囊卵巢综合征的疗效分析[J].中国计划生育和妇产科,2014,(04):0.
　LI Shu-hong,[J].Chinese Journal of Family Planning & Gynecotokology,2014,(6):0.
[7]倪仁敏,杨冬梓.多囊卵巢综合征的发病概况[J].中国计划生育和妇产科,2014,(06):0.
[8]崔琳琳,陈子江.多囊卵巢综合征的临床诊断要点[J].中国计划生育和妇产科,2014,(06):0.
[9]刘义.多囊卵巢综合征长期管理与治疗策略[J].中国计划生育和妇产科,2014,(06):0.
[10]李尚为.多囊卵巢综合征的促排卵治疗[J].中国计划生育和妇产科,2014,(06):0.

备注/Memo

备注/Memo:
国家自然科学基金资助项目（项目编号：81472438、81272874）；盛京自由研究者基金（项目编号：201601）
更新日期/Last Update: 2019-06-25